The monitoring of potential long-term complications in treated adult cancer patients

Annals of Saudi Medicine

Volumn 17, Issue 6, 1997, Pages 622-628

  Brigden, Malcolm L ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CANCER RECURRENCE; CANCER THERAPY; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM; FOLLOW UP; HUMAN; LIVER INJURY; METASTASIS; NEUROTOXICITY; PATIENT MONITORING; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; REVIEW; SEPSIS; SPLENECTOMY;

EID: 0031394054     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.1997.622     Document Type: Review

References (50)

1. Delaat CA, Lampkin BC. Long-term survivors of childhood cancer: evaluation and identification of treatment. CA Cancer J Clin 1992;42:263-82.
2. Connors JM. The cured lymphoma patients: guidelines for long-term follow-up. Postgrad Med 1982;72:53-59.
3. Greene MH, Clark WH, Tucker MA, et al. Current concepts: acquired precursors of cutaneous malignant melanoma. N Engl J Med 1985;312:91-7.
4. Stierer M, Rosen HR. Influence of early diagnosis on prognosis of recurrent breast cancer. Cancer 1989;64:1128-31.
5. Shalet SM. Disorders of the endocrine system due to radiation and cytotoxic chemotherapy. Clin Endocrinol 1983;18:637-9.
6. Clayton PE, Shalet SM. Dose dependency of time of onset of radiation-induced growth hormone deficiency. J Pediatr 1991;118:226-8.
7. Salomon F, Cyneo RC, Hespr R, et al. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989;321:1797-803.
8. Littley MD, Shalet SM, Beardwell CG, et al. Radiation-induced hypopituitarism is dose dependent. Clin Endocinol 1989;31:361-73.
9. Constine LS, Woolf PD, Cann D, et al. Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 1993;328:87-94.
10. Sklar CA, Kim TH, Ramsay NKC. Thyroid function among long-term survivors of bone marrow transplantation. Am J Med 1982;73:688-94.
11. Devney RB, Sklar CA, Nesbit ME, et al. Serial thyroid function measurements in children with Hodgkin's disease. J Pediatr 1984;105:223-7.
12. Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991;325:599-605.
13. Beard CM, Heath III H, O'Fallon M, et al. Therapeutic radiation and hyperparathyroidism: a case control study in Rochester, Minn. Arch Int Med 1989;149:1887-90.
14. Meirow D, Schenker JG. Cancer and male infertility. Hum Reprod 1995;10:2017-22.
15. Pryzant RM, Meistrich ML, Wilson G, et al. Long-term reduction in sperm count after chemotherapy with and without radiation for non-Hodgkin's lymphoma. J Clin Oncol 1993;11:239-47.
16. Santoro A, Bonadonna G, Valagussa P, et al. Long-term results of combined chemotherapy radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. J Clin Oncol 1989;5:27-37.
17. Rivkees SA, Crawford JD. The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAMA 1988;259:2123-5.
18. Horning SJ, Hoppe RT, Kaplan HS, Rosenberg SA. Female reproductive potential after treatment for Hodgkin's disease. N Engl J Med 1981;304:1377-82.
19. Wallace WHB, Shalet SM, Hendry JH, et al. Ovarian failure following abdominal irradiation in childhood: the radiosensitivity of the human oocyte. Br J Radiol 1981;62:995-8.
20. Kreuser ED, Felsenberg D, Behles C, et al. Long-term gonadal dysfunction and its impact on bone mineralization in patients following COPP/ABVD chemotherapy for Hodgkin's disease. Ann Oncol 1992;3:105-10.
21. Mulvihill JJ, Myers MH, Connelly RR, et al. Cancer in offspring of long-term survivors of childhood and adolescent cancer. Lancet 1987;2:813-7.
22. Green DM, Zevon MA, Lowrie G, et al. Congenital anomalies in children of patients who received chemotherapy for cancer in childhood and adolescence. N Engl J Med 1991;325:141-6.
23. Hancock SL, Donaldson SS, Hopper RT. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 1993;11:1208-15.
24. Mittal B, Deutsch M, Thompson M, Dameshek HC. Radiation-induced accelerated coronary arteriosclerosis. Am J Med 1986;81:183-4.
25. Shan K, Lincoff AM, Young JB. Anthracycline-induced cardiotoxicity. Ann Int Med 1996;125:47-58.
26. Steinherz L, Steinherz P, Tan C, et al. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 1991;266:1672-7.
27. Postma A, Bink-Boelkens MT, Beaufort-Kfrol GC, et al. Late cardiotoxicity after treatment for a malignant bone tumour. Med Pediatr Oncol 1996;26:230-7.
28. Berger CC, Bokemeyer C, Schneider M, et al. Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer. Eur J Can 1995;31:2229-38.
29. Kreisman H, Wolkove N. The pulmonary toxicity of antineoplastic agents. Semin Oncol 1992;19:508-20.
30. O'Driscoll BR, Hasleton PS, Taylor PM, et al. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. N Engl J Med 1990;323:378-82.
31. Bauer KA, Skarin AT, Balikian JP, et al. Pulmonary complications of chemotherapy regimens containing bleomycin. Am J Med 1983;74:557-63.
32. Horning SJ, Adhikari A, Rizk N, et al. Effect of treatment for Hodgkin's disease and pulmonary function: results of a prospective study. J Clin Oncol 1994;12:297-305.
33. Perry MC. Chemotherapeutic agents and hepatotoxicin. Semin Oncol 1992;19:551-65.
34. Parker D, Bate CM, Craft AW. Liver damage in children with acute leukemia and non-Hodgkin's lymphoma on oral maintenance chemotherapy. Cancer Chemother Pharm 1980;4:121-7.
35. Locasciulli A, Vergani GM, Uderzo C, et al. Chronic liver disease in children with leukemia in long-term remission. Cancer 1983;52:1080-7.
36. Patterson WP, Ream SGP. Renal toxicity of chemotherapy. Semin Oncol 1992;19:521-8.
37. Rossi R, Danzebrink S, Hillebrand D, et al. Ifosfamide-induced subclinical nephrotoxicity and its potentiation by cisplatinum. Med Pediatr Oncol 1994;22:27-32.
38. Robitaille P, Mongeau JG, Lortie L, Sinnassamy P. Long-term follow-up of patients who underwent unilateral nephrectomy in childhood. Lancet 1985;1:1297-9.
39. Pedersen-Bjergaard J, Ersboll J, Hansen VL, et al. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma. N Engl J Med 1988;318:1028-32.
40. Fu KK, Kai EF, Leung CK. Cisplatin neuropathy: a prospective clinical and electrophysiological study in Chinese patients with ovarian carcinoma. J Clin Pharm Ther 1995;20:167-72.
41. Chaudhry V, Rowinsky EK, Sartorius SE, et al. Peripheral neuropathy from taxol and cisplatinum combination chemotherapy: clinical and electrophysiological studies. Ann Neural 1994;35:304-11.
42. Freilich RJ, Kraus DH, Budnick AS, et al. Hearing loss in children with brain tumours treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue. Med Pediatr Oncol 1994;26:95-100.
43. Packer RJ, Meadows AT, Rorke LB, et al. Long-term sequelae of cancer treatment on the central nervous system in childhood. Med Pediatr Oncol 1987;15:241-53.
44. Byrne J, Fearn TR, Steinhorn SC. Marriage and divorce after childhood and adolescent cancer. JAMA 1989;262:2693-9.
45. Holmes GE, Baker A, Hassanein RS, et al. The availability of insurance to long-term survivors of childhood cancer. Cancer 1989;57:190-3.
46. Brigden ML. Overwhelming postplenectomy infection: still a problem. West J Med 1992;157:440-3.
47. Schwartz JS. Immunisation Practices Advisory Committee: Pneumococcal polysaccharide vaccine. MMWR 1989;38:64-76.
48. Pui CH, Ribiero RC, Hancock ML, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 1991;325:1682-7.
49. Ballen KK, Antin JH. Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndrome. Hem Oncol Clin North Am 1993;7:477-93.
50. Tucker MS, Coleman CN, Cox RS, Varghese A, Rosenberg SA. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med;318:76-81.